Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Trial of SBRT Versus Hypofractionated Radiotherapy for Salvage of Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma After Radical Prostatectomy

NCT06205316 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06205316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06205316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Trial of SBRT Versus Hypofractionated Radiotherapy for Salvage of Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma After Radical Prostatectomy
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 4, 2024
Completion date
September 25, 2028
Enrollment
118 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

biochemically recurrent prostate carcinoma, oligometastatic prostate carcinoma, recurrent prostate adenocarcinoma, stage iib prostate cancer ajcc v8, stage iic prostate cancer ajcc v8, stage iii prostate cancer ajcc v8, stage iv prostate cancer ajcc v8